tetano
Editor, Senior Moderator
J Med Case Rep
. 2021 May 28;15(1):305.
doi: 10.1186/s13256-021-02782-w.
Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report
Jonathan Solaimanzadeh[SUP] 1 2 [/SUP], Aaron Freilich[SUP] 2 3 [/SUP], Michael R Sood[SUP] 4 5 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 2019 (COVID-19) has been shown to have extensive effects on the cardiovascular system. Its long-term cardiac manifestations, however, remain unclear.
Case presentation: We report the case of a Caucasian patient with a mild and self-limited presentation of COVID-19, with subsequent development, months later, of exertional dyspnea and non-sustained ventricular tachycardia, long after resolution of his illness and after returning to aerobic exercise. The patient had normal screening tests including electrocardiogram (ECG) and echocardiogram 4 months after his illness. Cardiac magnetic resonance imaging demonstrated epicardial and pericardial fibrosis of the right ventricle free wall and outflow tract and the pericardium over the anterior wall, 6 months following the initial infection. First abnormal ECG was recorded at month 7 following illness.
Conclusions: This case suggests an insidious and possible long-term cardiac involvement and reflects the challenges in traditional workups and screening modalities in identifying cardiac involvement in COVID-19.
Keywords: COVID-19; Cardiovascular magnetic resonance; Late gadolinium enhancement; SARS-CoV-2; Ventricular tachycardia.
. 2021 May 28;15(1):305.
doi: 10.1186/s13256-021-02782-w.
Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report
Jonathan Solaimanzadeh[SUP] 1 2 [/SUP], Aaron Freilich[SUP] 2 3 [/SUP], Michael R Sood[SUP] 4 5 [/SUP]
Affiliations
- PMID: 34049584
- DOI: 10.1186/s13256-021-02782-w
Abstract
Background: Coronavirus disease 2019 (COVID-19) has been shown to have extensive effects on the cardiovascular system. Its long-term cardiac manifestations, however, remain unclear.
Case presentation: We report the case of a Caucasian patient with a mild and self-limited presentation of COVID-19, with subsequent development, months later, of exertional dyspnea and non-sustained ventricular tachycardia, long after resolution of his illness and after returning to aerobic exercise. The patient had normal screening tests including electrocardiogram (ECG) and echocardiogram 4 months after his illness. Cardiac magnetic resonance imaging demonstrated epicardial and pericardial fibrosis of the right ventricle free wall and outflow tract and the pericardium over the anterior wall, 6 months following the initial infection. First abnormal ECG was recorded at month 7 following illness.
Conclusions: This case suggests an insidious and possible long-term cardiac involvement and reflects the challenges in traditional workups and screening modalities in identifying cardiac involvement in COVID-19.
Keywords: COVID-19; Cardiovascular magnetic resonance; Late gadolinium enhancement; SARS-CoV-2; Ventricular tachycardia.